A Danish biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases. Its business model centers on proprietary antibody platforms and partnerships with large pharmaceutical companies, generating significant royalty revenue from marketed drugs such as m...
No congressional trades have been disclosed for genmab a/S american Depositary (GMXAY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.